PPIs
Research Roundup
Debbie Rigby rounds up the latest in research news Proton‐Pump Inhibitors and Long‐Term Risk of Community‐Acquired Pneumonia in Older Adults In a large cohort of older adults in primary care, …
Research Roundup
Debbie Rigby takes a look at the latest in research news Diagnosis and management of Parkinson’s disease in adults In July 2017, NICE updated its 2006 guideline on Parkinson’s disease …
Research Roundup
Debbie Rigby rounds up the latest in research news Fall-Risk-Increasing Drugs Use of certain medications is recognized as a major and modifiable risk factor for falls. In this systematic review …
Research Roundup
Debbie Rigby takes a look at the latest in research news Development of a clinical pharmacy model within an Australian home nursing service This paper describes a collaborative, person-centred model …
Research Roundup
Debbie Rigby takes a look around at the latest in research news Effect of vitamin D supplementation on non-skeletal disorders This systematic review explored more recently published meta-analyses and randomised …
PPI-stomach cancer link highlighted
ASMI has issued a statement saying consumers can be confident in the safety profile of OTC proton pump inhibitors A study published in Gut has shown that people who regularly …
Research Roundup
Debbie Rigby takes a look at the latest in research news We have had a gutful: The need for deprescribing proton pump inhibitors Times series analysis of PBS and RPBS …
S3 esomeprazole to go S2
The Schedule 3 entry for proton-pump inhibitor esomeprazole is set to be deleted from 1 February 2018 The TGA delegate has made an interim decision to downschedule the PPI to Pharmacy …
Research Roundup
Debbie Rigby takes a look at the latest in research news Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL …
Research Roundup
Debbie Rigby takes a look at the latest in research news Role of Direct Oral Anticoagulants in the Management of Anticoagulation This article reviews the roles of dabigatran, rivaroxaban, apixaban, …
PPI link to higher death risk
ASMI has moved to reassure patients after a study linked PPIs to a higher risk of death The study’s authors have suggested it may be time to restrict the indications …
Research Roundup
Debbie Rigby rounds up the latest in research news Benzodiazepines, Z-drugs and the risk of hip fracture There is strong evidence that both BNZ and Z-drugs are associated with an …